Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing. [PDF]
Massie J +4 more
europepmc +1 more source
Misfolding PRSS1 variant p.Ala61Val in a case of suspected intrauterine pancreatitis. [PDF]
Sándor M +7 more
europepmc +1 more source
Newborn Screening Program for Cystic Fibrosis in Türkiye: Experiences from False-Negative Tests and Requirement for Optimization [PDF]
Çoksüer F +10 more
europepmc +1 more source
Celebrating 50 Years of Nationwide Newborn Screening in Hungary-Review, Current Situation, and Future Directions. [PDF]
Monostori P +23 more
europepmc +1 more source
Cystic Fibrosis of the Pancreas: In Vitro Duct Models for CFTR-Targeted Translational Research. [PDF]
Ludovico A, Battistini M, Baroni D.
europepmc +1 more source
Pilot Evaluation of Intestinal Current Measurement in Cystic Fibrosis and CRMS/CFSPID Patients in Poland. [PDF]
Postek M +4 more
europepmc +1 more source
Clinical Course of a Child With Cystic Fibrosis and the Genotype F508del/CFTRdup1_11: A Case Report. [PDF]
Petrocheilou A, Tzetis M, Loukou I.
europepmc +1 more source
Trypsin and Trypsinogen Activation Peptide in the Prediction of Severity of Acute Pancreatitis. [PDF]
Allemann A, Staubli SM, Nebiker CA.
europepmc +1 more source
Evaluating the Impact of Newborn Screening for Cystic Fibrosis in Portugal: A Decade of Insights and Outcomes. [PDF]
Camacho B +15 more
europepmc +1 more source

